Chicago Cornea Logo

Randy J. Epstein, M.D., Bibliography


  1. Epstein RJ, Hughes WF: “Lymphocyte-induced corneal neovascularization: A morphologic assessment”. Invest Ophthalmol Vis Sci 21 (1):87-94, 1981.
  2. Miller MT, Epstein RJ, Sugar J, et. al.: “Anterior segment anomalies associated with the fetal alcohol syndrome”. J Ped Ophthalmol and Strabismus 21:8, 1984.
  3. Epstein RJ, Wilson LA, Visvesvara GS, Plourde E: “Rapid diagnosis of Acanthamoeba keratitis from corneal scrapings using indirect fluorescent antibody staining”. Arch Ophthalmol 104:1318, 1986.
  4. Epstein RK, Halkias A, Stulting RD, and Rodrigues MM: “Corneal opacities and anterior segment anomalies in DBA/2 mice: Models for corneal elastosis and the iridocorneal endothelial (ICE) syndrome”. Cornea 5:95, 1986.
  5. Epstein RJ, Fernandes A, Stulting RD, Tigges M, Wright JD, and Gammon JA: “The correction of aphakia in neonatal monkeys with extended-wear contact lenses: Corneal studies”. Ophthalmology 93: 1495, 1986.
  6. Epstein RJ, Stulting RD, and Kindle JC: “Blastogenesis induced by Herpes simplex virus in splenic mononuclear cells from inbred mice”. Curr. Eye Res. 6:145, 1987.
  7. Epstein RJ, and Stulting RD: “Corneal neovascularization induced by stimulated lymphocytes in inbred mice”. Invest Ophthalmol Vis Sci 28: 1505, 1987.
  8. Epstein RJ, Seedor JA, Dreizen NG et al.: “Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival”. Ophthalmology 94: 935, 1987.
  9. Epstein RJ, Stulting RD, Hendricks RL, Harris DM: “Corneal neovascularization: Pathogenesis and inhibition”. Cornea 6:250-257, 1987.
  10. Moore MB, McCulley JP, Newton C, Cobo LM, Foulks G, O’Day D, Johns K, Driebe WT, Wilson LA, Epstein RJ, Doughman DJ: “Acanthamoeba keratitis: A growing problem in soft and hard contact lens wearers”. Ophthalmol 94: 1654,1987.
  11. Epstein RJ, Fernandes A, Gammon JA: “The correction of aphakia in infants with hydrogel extended-wear contact lenses: Corneal studies.” Ophthalmol 95: 1102-1106, 1988.
  12. Visvesvara GS, Epstein RJ, et al: “Acanthamoeba keratitis associated with contact lenses-United States”. Morbidity and Mortality Weekly Report 35:405, 1988.
  13. Driebe WT Jr., Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T: “Acanthamoeba keratitis: Potential role for topical clotrimazole in combination chemotherapy”. Arch Ophthalmol 106:1196-1201, 1988.
  14. Epstein RJ, Vastine DW, Fried WI: “Removing the Stableflex intraocular lens during penetrating keratoplasty”. Ophthalmic Surg 20:171-172, 1989.
  15. Hendricks RL, Epstein RJ, Tumpey T: “The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis in mice”. Invest Ophthalmol Vis Sci. 30:105-115, 1989.
  16. Epstein RJ, Hendricks RL, Stulting RD: “Interleukin-2 induces corneal neovascularization in A/J mice”. Cornea 9:318-323, 1990.
  17. Hendricks RL, Barfknecht CF, Schoenwald RD, Epstein RJ, Sugar J: “The effect of flurbiprofen on herpes simplex virus type I stromal keratitis in mice”. Invest Ophthalmol Vis Sci 31:1503-1511, 1990.
  18. Hendricks RL, Epstein RJ, Viana MAG, Hoffman DA: “A reproducible method for injecting the mouse corneal stroma”. Invest Ophthalmol Vis Sci 32:366-370, 1991.
  19. Epstein RJ, Hendricks RL, Harris DM: “Photodynamic therapy for corneal neovascularization”.  Cornea 10:424-432, 1991.
  20. Holland EJ, Alul IH, Meisler DM, Epstein RJ, et al.: “Sub-epithelial infiltrates in Acanthamoeba keratitis”. Am J Ophthalmol 112:414-418, 1991.
  21. Lipman RM, Epstein RJ, Hendricks RL: “Suppression of corneal neovascularization by cyclosporine”. Arch Ophthalmol 110:405-407, 1992.
  22. Nelson JD, Gordon JF, and the Chiron Keratoconjunctivitis Sicca Study Group: “Topical fibronectin in the treatment of keratoconjunctivitis sicca.” Am J Ophthalmol 114:441-447, 1992.
  23. Kay MD, Epstein RJ, Torczynski E: “Histopathology of acute intraoperative suprachoroidal hemorrhage associated with transscleral intraocular lens fixation”. J Cataract Refract Surg 19:83-87, 1993.
  24. Epstein RJ, Eiden SB: “Circumscribed posterior keratoconus”. J. Am. Optom Assn., 66:189-193, 1995.
  25. Baca LS, Epstein RJ: “Closed-chamber capsulorhexis for cataract extraction combined with penetrating keratoplasty”. J Cataract Refract Surg: 24: 581-584, 1998.
  26. Karp KO, Flood TP, Wilder AL, Epstein RJ: “Photic Maculopathy after Pterygium Excision”, AJO 128; 248-250, 1999.
  27. Konowal A, Morrison JC, Brown SVL, Cooke DL, Maguire LJ, Verdier DV, Fraunfelder FT, Dennis RF, Epstein RJ: “Irreversible corneal decompensation in patients treated with topical dorzolamide”, Am J Ophthalmol 127; 403-406, 1999
  28. Majmudar PA., Forstot SL, Dennis RF, Nirankari VS, Damiano RE, Brenart R,  Epstein RJ: “Topical Mitomycin-C for subepithelial fibrosis after refractive corneal surgery”, Ophthalmol., 107:89-94, 2000.
  29. Karp KO, Hersh PS, Epstein RK: “Delayed keratitis after laser in-situ keratomileusis”, J Cataract Surg, 26: 925-928, 2000.
  30. Rao SN, Epstein RJ: Early onset ectasia following laser in-situ keratomileusis: Case report and literature review”. J. Refr. Surg 18: 177-184, 2002.
  31. Tang-Liu, DDS, Small D, Acheampong A, Reis B, Stern K, Stewart W, Berdy G, Epstein RJ, Forster R, Forstot L: “Blood concentrations of cyclosporin A during long-term treatment with cyclosporin A ophthalmic emulsions in patients with moderate to severe dry eye disease.” J Ocular Pharmacol and Therapeutics, 2002
  32. Rao S, Raviv T, Majmudar PA, Epstein RJ: “Role of ORBScan II in screening kerato-conus suspects before refractive corneal surgery”. Ophthalmol 109:1642-1646, 2002,
  33. Rao S, Konowal A, Murchison AE, Epstein RJ: “Enlargement of the temporal clear corneal incision to treat pre-existing astigmatism.” J Refract Surg 18:463-467. 2002.
  34. Muller LT, Candal EM, Epstein RJ, Dennis RF, Majmudar PA: “Transepithelial phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with adjunctive mitomycin-C for complicated LASIK flaps”. J Cat Refr Surg 31: 291-296, 2005
  35. Spanggord HM, Epstein RJ, Lane HA, Candal, EM, Klein, SR, Majmudar PA, Dennis RF: “Flap Suturing with Proparacaine For Recurrent Epithelial Ingrowth Following LASIK Surgery”. J Cat Refr Surg 31:916-921, 2005.
  36. Sheppard, JD, Epstein, RJ, Lattanzio FA, Marcantonio, D and Williams, PB: Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphrin ether.  Am J Ophthalmol 141: 524-529, 2006.
  37. Klein, SR, Epstein RJ, Randleman JB, and Stulting RD: “Corneal ectasia after laser-in situ keratomileusis in patients without apparent preoperative risk factors.  Cornea 25: 388-403, 2006.
  38. Majmudar, PA Epstein RJ, Parent A, Raphtis EM, Grostern R, Torczinski E. : Noninvasive diagnosis of epithelial downgrowth after penetrating keratoplasty using immunohistochemical analysis of resected corneal buttons. Cornea 25:727-733, 2006.
  39. Goldsberry DH, Epstein RJ, Majmudar PA, Epstein RH, Dennis RF, Holley G, Edelhauser HF: “Effect of Mitomycin C on the Corneal Endothelium When Used for Corneal Subepithelial Haze Prophylaxis Following Photorefractive Keratectomy.” J Refract Surg. 23:724-727, 2007
  40. Davis, MJ, Epstein, RJ, Dennis, RF, and Cohen JA: “Culture-positive endophthalmitis after implantation of intraocular Collamer lens”.  J Cat Refr Surg 35: 1826-28, 2009
  41. Virasch, V, Majmudar PA, Epstein RJ, et al: “Reduced Application Time for Prophylactic Mitomycin-C in Photorefractive Keratectomy”. Ophthalmol. 117: 885-89, 2009
  42. Elderkin, SJ, and Epstein, RJ, Seldomridge DL:“Successful Treatment of Recurrent Epithelial Ingrowth Associated With Interface Fluid Syndrome, Flap Necrosis, and Epithelial Defects Following LASIK” J Refract Surg 27:70, 2011.
  43. Lane SS, Dubiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE, Silbert DI, Blackie CA, Stevens CA, and Bedi R : A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 31 :396-404, 2012
  44. Hou JH, Tannan A, Rubenstein JB, Lopez OI, McCoy K, Epstein RJ, Grostern RJ, Sugar J : Clostridium Perfringens endophthalmitis after penetrating keratoplasty with contaminated corneal allografts : A case series. Cornea 34:23-27, 2015
  45. Dalal,R.R.; Raber,I.; Dunn,S.P.; Weisenthal,R.; Sugar,J.; Hannush,S.; Epstein,R.; Feder,R.S.: Epithelial ingrowth following endothelial keratoplasty, Cornea 35: 465-470, 2016
  46. Rubinfeld RS, Epstein RH, Majmudar PA, Kim D, Choi M, and Epstein RJ : Transepithelial crosslinking retreatment of progressive corneal ectasia unresponsive to classic crosslinking. J Cat Ref Surg 43 : 131-135, 2017


A. Non-Peer Review/“Tabloid” Articles Written, Edited, or Quoted in

  1. Epstein RJ and Waring GO, III: Aging and the cornea. Part 1. Conditions not associated with visual impairment. Geriatric Ophthalmol 1:20-30, 1985.
  2. Epstein RJ and Waring GO, III: Aging and the cornea. Part 2. Conditions that may lead to visual impairment Geriatric Ophthalmol 1:17-23, 1985.
  3. Epstein RJ, Allen RC, and Lunde MW: Organic impotence associated with carbonic anhydrase inhibitor therapy for glaucoma. Ann Ophthalmol 19:48, 1987.
  4. The Institute of Medicine of Chicago. Epstein RJ: Immunologic diseases of the anterior segment of the eye: Local and systemic. Proc Inst Med Chgo 42:52, April, 1989.
  5. Hennessey MJ, Epstein RJ: Preventing violation of optical zone during RK. Ocular Surgery News 11:97, 1993.
  6. Sjogren’s Syndrome Foundation National Newsletter, “The Moisture Seekers”. “Pharmacologic and surgical therapeutics for the dry eye”, March, 1994.
  7. Management of astigmatism during cataract surgery: Round table discussion: Maloney WF, Epstein RJ, Wallace RB, Kershner RM, Alpins NA, Richman RA: Ocular Surgery News, February, 1995 pp. 13-16.
  8. Epstein RJ: Life in a suburb: Physician cooperation brings RK to town, Ocular Surgery News 13:17, 1995.
  9. Epstein RJ, Kormehl E: Watch for decompensation with Trusopt. Ophthalmology Times, (O.T.) 22:12, 1997.
  10. Epstein RJ: LASIK can create happy patients and even happier staffs. O.T., 7/1/97
  11. Epstein RJ: Bilateral LASIK requires error-free surgery every time. O.T., 10/98
  12. Raviv T, Epstein RJ: Flat cornea and diplopia. Annals of Ophthalmology 2000: 32(2) 85-86.
  13. Raviv T, Epstein J, Majmudar PA: Mitomycin-C debridement can treat post-PRK haze. Ophthalmology Times, 2/00.
  14. Raviv T, Majmudar PA, Dennis RF, and Epstein RJ: Oxygen drying technique assures LASIK flap adherence. Ophthalmology Times, June, 2000.
  15. Rao SR, Majmudar PA, Epstein RJ: “Topography system can image posterior surface of cornea”, Ophthalmology Times, 26, No. 13, pg. 14, 2001.
  16. Epstein RJ: “Randy Epstein on Personal Experience of LTK”, Refractive Eyecare for Ophthalmologists 5:1, 2001.
  17. Rao S, Epstein RJ: “Large Study Finds Voltaren Safe Following Cataract Surgery”, Ocular Surgery News 19, No. 19; 12, 2001.
  18. Epstein RJ: Optimizing patient outcomes when using laser technology for refractive surgery. Ophth Management Suppl., 11/01, pg. 12-14.
  19. Epstein RJ, Muller LT, Spanggord HM: “Preventing glare and halos following LASIK surgery”. Ophthalmology Management (Suppl.), 9/02.
  20. Epstein, RJ et. al: “Risk management guidelines for refractive surgery”, Illinois State Medical Society Insurance Services (ISMSIS). Ophthalmology Risk-Management Sub-committee document (2002).
  21. Muller LT, Majmudar PA, Epstein RJ: “Mitomycin-C for post-PRK haze and complicated LASIK flaps”. Review of Refractive Surg. 4:15-17, 2003.
  22. Candal EM and Epstein RJ: “IOL selection issues after RK”. Cat Ref Surg   Today 3: 34-38, 2003.
  23. Muller LT, Packo KH, Spanggord HM, Epstein RJ: “Band keratopathy within a LASIK flap”. Cataract & Refract Surg Today 3:32-34, 2003.
  24. Candal, EM, Muller, LT, Dennis RF, Majmudar PA, Klein S, Epstein RJ: “Identifying keratoconus suspects with wavefront analysis”.  Cat. Ref. Surg. Today 4:52 -56, 2004.
  25. Klein SR, Epstein RJ, Mamalis, N, Werner L: “Late Opacification of the Memory Lens”.  Review of Refractive Surgery 5:17-18, 2004.
  26. Klein, Shawn R MD; Epstein, Randy J MD; Majmudar, Parag A MD; Muller, Laura T MD: Management of Complicated or Buttonhole LASIK Flaps with Transepithelial Phototherapeutic Keratectomy/ Photorefractive Keratectomy with Adjunctive Mitomycin C. Tech. in Ophthalmology. 2(3):110-113, Sept., 2004.
  27. Epstein, RJ: “Great expectations: Today’s refractive surgery patient”. Refractive Eyecare for Ophthalmologists 8:1, 2004.
  28. Talsma J. and Epstein, RJ: “Mitomycin-C after surface ablation can prevent corneal haze. Ophthalmology Times, 3/1/04, page 49.
  29. Gonzalez JM: “MMC can be used prophylactically in PTK, PRK to prevent corneal haze”: Ocular Surgery News (O.S.N.) 22: 3, 5/1/04
  30. Candal, EC, Seldomridge DL, Muller LT, and Epstein RJ: Wavefront analysis detects pellucid marginal degeneration before LASIK: O.S.N. 10/15/04, pp. 60-61.
  31. Klein SR, Epstein, RJ, Majmudar, PA, Muller LT: “Management of Complicated or Buttonhole LASIK Flaps With Trans-epithelial Phototherapeutic Keratectomy/ Photorefractive Keratectomy With Adjunctive Mitomycin C”. Techniques in Ophthalmology, Sept. 2004, Vol. 2, pp. 110-113.
  32. Bethke, Walter: “Refractive Surgery: Insights on Ectasia”: Review of Ophthalmology, March 2005, pp. 33-37.
  33. Karmel, Miriam: “Rethinking Mitomycin-C”: EyeNet, March 2005, pp. 35-39
  34. Faron CA and Epstein RJ: “Crystalens postop care similar to phaco cases”. Primary Care Optometry News, Vol. 10., Sept. 2005, p. 38.
  35. Epstein RJ, and Cutler R: “Chicago physician shares popular dining spots”.  O.S.N., Vol. 29, 10/1/05, p. 65.
  36. Klein, SR, Epstein RJ, Randleman JB, Stulting RD: “Ectasia without risk factors”. J Cat Ref Surg Today, July 2005, pp. 32-34.
  37. Guttman, C: “Post-LASIK ectasia possible with no known risk factors”.  Ophthalmology Times, 9/15/05, p. 57.
  38. Epstein, RJ, Herst, B, Goren, M, Gerstein, M, Brenner, S: “Exploring Liability Issues in Refractive Eye Surgery “, ISMIE Newsletter, Spring 2006.
  39. Seldomridge DL, Candal EM, Epstein RJ. “Wavefront analysis for keratoconus and Pellucid Marginal Degeneration”. Review of Ophthalmology 2005; 10:96-103
  40. Epstein, RJ, Groves N: “Prophylactic MMC helps prevent haze, improve acuity”.  O.T., 2/1/08, p. 36.
  41. Shovlin JP and Epstein, RJ: “Risk of ectasia worries patient”.  Review of Optometry 4/15/08, page 107.
  42.  Hasson, M: “Modified DSEK technique promotes graft fixation, prevents complications”.  O.S.N., 5/10/09, pg. 3.
  43. Boxer Wachler B, Epstein RJ, Brown SVL. Maguen E, Talley-Rostov AR : ‘Complications after the placement of a phakic IOL ‘.  Cataract & Refractive Surgery Today, October 2009, pg. 67.
  44. Bethke, W : ‘The best way to straighten a bow tie ‘. Rev. Of Ophthalmol.17 :28-31, Jan. 2010
  45. Chu, R, and Epstein RJ : ‘Rehabilitating a patient with extreme myopic astigmatism ‘. Premier Surgeon Vol. 2, pp. 10-11, 2011.
  46. Menke, Anne : ‘Surgical Team Briefings Reduce Malpractice Risks’ : OMIC Digest Fall 2011, V. 21, #4, page 1.
  47. Guell, J., ed. : ‘Refractive surgical problem’- Randy Epstein,  J Cat Ref Surg. 38 :554-559, 2012
  48. “LTK: What I Learned”. Refractive Eyecare 16:1, (May) 2012, edited by Ethis Communications Editorial Director, David Kellner
  49. ‘Easy as 123- Protect your eyes from UV rays’.  In ‘Discover Rush’, Summer 2012 (Rush Univ. Medical Center Periodical)
  50. Epstein RJ, Hardten DR, Hovanesian JA, Liang K, Shultz MC : ‘Controlling Perioperative Inflammation’, Cat & Refr Surg Today 12 :14, 2012
  51. Braga-Mele, R, Epstein, RJ, Katsev D, and Updegraff S : ‘Posterior corneal astigmatism and toric IOL’s’ – CRST Today’s topics, ed. by JF Doane,  April 2013 :18-19
  52. Epstein, RJ : ‘Preventative eye care goes a long way’- Vision- Spring 2013 (Illinois Eye Bank’s quarterly publication).
  53. Epstein, RJ, Epstein RH, Dennis RF, Majmudar, PA : Response to ‘Consultation Section : Corneal Surgical Problem’, J. Cat Ref Surg, 39 ;1618-1623 : 2013, Sect. Ed. : M. Moshirfar
  54. Lipner, Maxine : ‘Ocular Allergy Treatments’. EyeWorld, Feb. 2014, pp. 14-17
  55. Moshirfar, M., ed : ‘Anterior chamber surgical problem’ : RJ Epstein, JCRS 40 : 683-687, 2014
  56. Moshirfar M., ed. : ‘Corneal surgical problem’ : RJ Epstein, JCRS 40 :1747-1756, 2014
  57. Charters, Lynda : ‘Mitomycin C : Prophylactic, therapeutic, creative benefits’. Ophthalmology Times 2/15/15, p. 30.
  58. Cover Focus, ‘Meet the Epstein Family’ : CATARACT & REFRACTIVE SURGERY TODAY EUROPE | OCTOBER 2016.
  59. Cover Focus, ‘Family Tree : The Epsteins’ : CATARACT & REFRACTIVE SURGERY TODAY Feb., 2017, pp. 41-42
  60. Roach, Linda : ‘HORV and Cataract Surgery, Part 2 : Considering Alternatives to Vancomycin’, EyeNet, March 2017, pp. 27-29

B. Book Chapters

1. Epstein RJ and Stulting RD: “Immunologically mediated corneal neovascularization in inbred mice”. In: Ocular Circulation and Neovascularization. BenEzra D, Ryan SJ, Glaser BM, and Murphy RP. Eds, Martinus Nijhoff/Dr W. Junk Publ., Dordrecht, Netherlands, 1987, pp. 341-348.

2. Stulting RD, Abghari SZ, Epstein RJ, Nahmias AJ: “Host control of Herpes simplex virus Type-I (HSV) ocular disease in a genetically defined animal model.  In: The Cornea. Trans. of the World Congress on the Cornea III. Cavanagh HD, ed. Raven Press, Ltd., New York, NY, 1988, pp. 405-411.

3. Epstein RJ: Dendritic keratitis. “Will wiping it off wipe it out?”  In: Ophthalmic Clinical Debates. Deutsch TA, ed. Year Book Medical Publishers, Inc., Chicago, IL, 1989, pp . 88-93.

4. Basic and Clinical Science Course (BCSC), Section 8,  “External Disease and Cornea” (with co-authors: Schwab I, Harris, DJ, Pflugfelder, SC, Wilhelmus KR, Perry P), AAO, 1992 edition  5. Majmudar PA, Epstein RJ, “Antimetabolites in Ocular Surface Neoplasia” Schwab, I-ed. Current Opinion in Ophthalmology 9:IV: 35-39, 1998.

6. Raviv T, Epstein RJ. “Astigmatism Management”. Int. Ophthalmol. Clin.,   (Refractive Surgery) 40:3: 183-198, 2000.

7. Muller LT, Rao SN, Candal EM, Epstein, RJ. “Corneal Ectasia following LASIK   Surgery”. In Probst, LE: LASIK: Advances, Controversies, and Custom, 2004 (Chapter 17). Charles Slack, Inc., Thorofare, NJ 08086.

8. Letko E, Majmudar PA, Forstot SL, Epstein RJ, Rubinfeld RS: “UVA-light and Riboflavin-mediated Corneal collagen cross-linking”. In Trattler, W, Awdeh RM, Goldman DA: “Cornea/Refractive”, Spring 2011 (pp 63-76) Int. Ophthalmol. Clinics V. 51, #2, 2011. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia PA


  1. AAO Focal Points Monograph: Surgical Treatment of Pterygium- Gans LA, Vol. 14, #12, 1996. Reviewer and contributing editor.
  2. Gans L, Belin M, Epstein RJ, Wand M: “Surgical Treatment of Astigmatism”. AAO Focal Points Monograph 14: 12, 1996.



  1. Epstein RJ, Luskin AT, Rana A: “The polyglandular syndrome”. Ann Int Med 92:711, 1980.
  2. Epstein RJ, Mets MB, Wong PWK, Mizen T: “Uveal colobomas and Klinefelter’s syndrome”. Am J Ophthalmol 98:241-243, 1984.
  3. Epstein RJ, Vastine DW, Fried WI: “Refining the technique for removing the Stableflex lens.”  Ophthalmic Surg 20:599, 1989.
  4. Epstein RJ: “Viscoelastic agents”. Ophthalmic Surg 22:240, 1991.
  5. Epstein RJ: “Use of the disposable contact lens as a bandage contact lens”. Arch Ophthalmol 109: 1341, 1991.
  6. Epstein RJ: “Treatment of rheumatoid corneal ulcers”. Ophthalmology 99:842, 1992.
  7. Epstein RJ: “Transverse astigmatic keratotomy”. Refract Corneal Surg 8: 487, 1992.
  8. Epstein RJ: “General anesthesia and AISH”. J Cataract Refract Surg 19: 814, 1993.
  9. Epstein RJ, Robin JB: “Corneal graft rejection episode after excimer laser phototherapeutic keratectomy”. Arch Ophthalmol, 112:157, 1994.
  10. Epstein RJ: “Band keratopathy secondary to Herpes simplex or topical corticosteroid?” Arch Ophthalmol, 112: 578, 1994.
  11. Epstein RJ: “Refractive surgery goes mainstream: Establishing radial keratotomy services at a suburban community hospital”. J Refract Corneal Surg, 10: 378, 1994.
  12. Konowal A, Epstein RJ: “ALK vs. PK”.  Ocular Surgery News, 14:4. 1996.
  13. Epstein RJ: “Is advancing wave-like epitheliopathy distinct from whorled microcystic dystrophy?” Ophthalmology, 105: 4, 1998.
  14. Epstein RJ, Brown SVL, Dennis R, Konowal-Allen A: “Accommodation of systemic acetazolamide and topical dorzolamide”. Ophthalmol. 105: 9, 1998.
  15.  Epstein RJ: “Combining Keratoplasty and Cataract Surgery”. J Refract Corneal Surg, 25:603, 1999.
  16.  Epstein RJ: “Cyclosporine and neovascularization”. Ophth. 106: 3, 1999.
  17. Raviv T, Majmudar PA, Dennis RF, Epstein RJ: “Mitomycin-C for post-PRK haze”. J Cat Ref Surg 26:1105, 2000.
  18. Majmudar PA, Raviv T, Dennis RF, Epstein RJ: “Subepithelial fibrosis after RK”. J Cat. Refract. Surg, 26: 113, 2000.
  19. Epstein RJ: “Extending the Standard Temporal Incision”. J Cat. Refract. Surg, 26: 1697-98, 2000.
  20. Epstein RJ: “Triple Anterior Stromal Ring Infiltrate Associated with Presumed HSV Keratitis”. Cornea 20(8):904-906, 2001.
  21.  Rao S, Majmudar PA, Epstein RJ: “Transepithelial PTK/PRK Over Complicated LASIK Flaps”. J. Refract Surg: 17:47, 2001.
  22. Epstein RJ, Majmudar PA: “Pepper Spray in the Eye”. Ophthalmology 108: 1712, 2001.
  23. Epstein RJ: “Effect of topical trifluridine on Thygeson’s superficial punctate keratitis”. Ophthalmology 2002.
  24. Epstein RJ:  “Control of Astigmatism in Cataract Surgery”.  J Refr Surg 19. 9/03
  25. Epstein RJ, Brown SVL, Konowal A: “Endothelial changes associated with      topical dorzolamide do appear to be significant”. Arch Ophthalmol 122;1089, 2004.
  26. Epstein RJ: “Words of praise”. Cat Refr Surg Today 4:15, June 2004
  27. Epstein, RJ and Majmudar, PA: “Alternative approach to the treatment of        subepithelial fibrosis following radial keratotomy”.  Arch Ophthalmol 124:288, 2006.
  28. Klein, SR and Epstein RJ: “Ectasia after Photorefractive Keratectomy”. Ophthalmology 114:395-96, 2007.
  29. Epstein, RJ and Rao SN: “Early onset ectasia following LASIK: Long-term follow-up and correction”: J. Refract. Surg. 25: 250, 2009
  30. Larsen, B, Epstein RJ, Brown SVL: “Diagnosis of post-LASIK Chandler syndrome”. J Cat Refract Surg 35:3-4, 2009
  31. Davis, MJ, Packo KH, Epstein, RJ, Grostern RJ, and Cohen JA: Acanthamoeba endophthalmitis following penetrating keratoplasty for Acanthamoeba keratitis.  Arch Ophthalmol 128: 505, 2010
  32. Tailor UA and Epstein RJ: Corneal ectasia after laser in situ keratomileusis after laser thermal keratoplasty.  Cornea 29: 480, 2010
  33. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today European Edition (CRST), 10/16- “Cover Focus: Meet the Epstein Family”, pp. 2-4.
  34. Epstein, RJ and Epstein RH: Cataract and Refractive Surgery Today US Edition (CRST), Feb., 2017- Cover Focus: “Family Tree”. ‘The Epsteins’- Vol. 17, pp. 41-46
  35. Brennan, K, Editor: Cover Focus- “Is Cross-linking at a Crossroads?”, Review of Ophthalmology, Spt. 2017, pp. 23-28.

Book Reviews

1. Epstein RJ: Re: Brightbill F, “Corneal Surgery. Theory, Technique, and Tissue, 2nd Edition”. Am J Ophthalmol 547: 1994.

2. Epstein RJ, Majmudar P: “Excimer Lasers in Ophthalmology. Principles and Practice.” Miller N, McGhee C, Taylor H, Gartry D, Trokel S., Boston, MA. Am J Ophthalmol, 1997.

LASIK , or Laser-Assisted In Situ Keratomileusis, is a surgical procedure that is designed to reduce your dependency on glasses and contact lenses. Here at Chicago Cornea Consultants, Ltd., our LASIK surgeons use the latest in laser vision correction technology to ensure each patient receives optimal results.
Laser Vision
As leaders in the field of ophthalmology, we were among the first in the area to offer the advanced Alcon LenSx laser platform for cataract surgery. This exciting new technology allows our skilled ophthalmologists to make incredibly precise modifications, enhancing the patient experience.
cataract &
iol surgery
Traditionally, presbyopia, which happens to all of us as we age, has always meant glasses for clear reading vision. It's a condition not even correctable by laser vision correction. Luckily, there is an option. Refractive lens exchange allows patients a clear alternative to reading glasses and is capable of reducing or eliminating presbyopia by using an advanced multifocal intraocular lens.
refractive lens
exchange/phakic iol's
Keratoconus describes a cornea that weakens as collagen fibers deteriorate, causing the cornea to adapt a cone-like shape. Keratoconus can cause blurred vision, light sensitivity, glares, and decreased night vision. In its early stages, keratoconus may be treated with the use of prescription glasses or contact lenses.  Keratoconus is also one of the most common reasons for corneal transplant, and one of the most successful. call any of our offices and ask to speak to the Vision Correction Surgical Coordinator, or use the contact form below.
It's estimated that a million or more Americans have glaucoma and don't even know it.  People with glaucoma often do not experience any symptoms until they begin losing their peripheral vision. One of the scariest things about glaucoma is that it usually has no symptoms in the early stages, earning glaucoma the name "silent thief of sight." Anyone can be at risk, so it's important to have your vision regularly examined.
At Chicago Cornea Consultants, our doctors take great care in maintaining ocular health for our patients. However, a number of our patients voice concerns regarding soft lines and wrinkles around the eyes and other regions of the face. We have responded by introducing cosmetic procedures like BOTOX® Cosmetic through our Chicago practice.
Loss of near vision, or presbyopia, happens when your natural lens loses elasticity, making it difficult to change your focus to see objects up close.  It affects most people in their 40s and early 50s. The hassle and inconvenience of readers is driving many patients to look for a better way to improve their near vision without glasses. The Raindrop Near Vision Inlay is a simple solution to presbyopia. This innovative and unique procedure is an effective alternative to the hassle of readers. Raindrop Near Vision Inlay is a minimally invasive and long term solution to improve near vision without glasses.
reading vision
Contact lenses are medical devices which interact directly with the ocular surface of the eye. At Chicago Cornea Consultants, we provide exceptional care to ensure that you obtain the best possible vision with contact lenses that fit appropriately and maximize health benefits.